MRES Comptes : Analyse IA Institute of Biomedical Research Corp

Accueil

Stock

MRES

Comptes financiers

MRES Financier

Institute of Biomedical Research Corp

42.85%

$0

À la fermeture : Apr 02, 16:00:00 GMT-4

Post-Marché: Apr 02, 20:00:00 GMT-4

Aperçu Prévision Gagner Dividendes Comptes financiers

Statistiques clés

Clôture préc.

$0.0014

Prix d'ouverture

$0.002

Plage de la journée

$0.002 - $0.002

Plage de 52 semaines

$0.0007 - $0.0241

Volume

940.0K

Volume moyen

812.7K

Rendement en dividend

BPA (TTM)

Capitalisation boursière

$4.7M

Qu’est-ce que MRES ?

Institute of BioMedical Research Corp. engages in research and development, quality control and standardization of pharmaceuticals, cosmetics and food products. The company is headquartered in Niksic, Niksic. The company went IPO on 2000-10-27. The firm's services include scientific research and biomedical services, such as research and development, quality control, standardization of pharmaceuticals, cosmetics and food products. The firm also provides long-term biomedical and environmental research projects, develops new diagnostic biomedical technologies and experimental medical treatments. The firm's products include Aerosan, MicrobEX, Microbicidal Towels KleNET, OralNet, Oral Ocean Power and Purilair. The company offers electro medical devices, such as BioMed 2000 XT with Timer, BioStim INF, QuadStar Elite, QuadStar II, Pain Gone piezo-electric pain relief and Portable Ultra Sound Device. The company offers various services, including quality control services, regulatory services, healthcare services, environmental analyses, building decontamination, and environmental protection and management.



Fonctionnalités

Copilote IA pour actions et cryptomonnaies

Prédiction des prix

Suivi des collectes de fonds

Thèmes

Comparaison de cryptomonnaies

Ressources

Marché

Marché boursier américain

Marché boursier de Hong Kong

Marché crypto

Conditions d’utilisation Politique de confidentialité Plan du site

Revenus

État de situation

Flux de trésorerie

Annuel

Trimestriellement

MRES Revenu

Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.

Breakdown	TTM	12/31/2006	12/31/2005	12/31/1999	12/31/1998
Revenus	0	0	0	0	0
Croissance des revenus (H/H)	--	--	--	--	--
Coût des ventes	0	--	--	0	0
Bénéfice brut	0	--	--	0	0
Vente, Général et Administration	0	6	8	0	0
Recherche et développement	--	--	--	--	--
Frais d'exploitation	0	6	8	0	0
Autres revenus (charges) non opérationnels	0	0	0	--	--
Bénéfice avant impôts	0	-6	-8	0	0
Charge d'impôt sur le revenu	0	0	0	0	0
Bénéfice net	0	-6	-8	0	0
Croissance du bénéfice net	--	-25%	--	--	--
Actions en circulation (diluées)	19.1	180.36	140.29	6.58	0.48
Variation des actions (H-H)	--	28.99%	--	1,258%	--
EPS (dilué)	-0.02	-0.03	-0.05	-0.04	-0.2
Croissance du EPS	--	-40%	--	-78%	--
Flux de trésorerie libre	0	-3	-5	0	0
Flux de trésorerie libre par action	--	--	--	--	--
Marge brute	0%	--	--	0%	0%
Marge opérationnelle	0%	0%	0%	0%	0%
Marge bénéficiaire	0%	0%	0%	0%	0%
Marge du flux de trésorerie libre	0%	0%	0%	0%	0%
EBITDA	0	-6	-8	0	0
Marge EBITDA	0%	0%	0%	0%	0%
D&A pour le résultat opérationnel	0	0	0	0	0
EBIT	0	-6	-8	0	0
Marge EBIT	0%	0%	0%	0%	0%
Taux d'imposition effectif	0%	0%	0%	0%	0%

Follow-Up Questions

Báo cáo tài chính chính của Institute of Biomedical Research Corp là gì?



Theo báo cáo tài chính mới nhất (Form-10K), UDS Group Inc có tổng tài sản là $0, lợi nhuận ròng perte là $-6

Tỷ lệ tài chính chính của MRES là gì?



Tỷ lệ thanh khoản của UDS Group Inc là 0, tỷ suất lợi nhuận ròng là 0, doanh thu trên mỗi cổ phiếu là $0.

Doanh thu của Institute of Biomedical Research Corp được phân bổ theo phân khúc hoặc khu vực địa lý như thế nào?



Le segment de revenus le plus important est UDS Group Inc, avec un chiffre d'affaires de Vetcomm lors du dernier rapport de résultats. En termes géographiques, United States est le marché principal pour UDS Group Inc, avec un chiffre d'affaires de 419,299.

Institute of Biomedical Research Corp có lợi nhuận không?



non, theo báo cáo tài chính mới nhất, UDS Group Inc có lợi nhuận ròng perte là $-6

Institute of Biomedical Research Corp có nợ không?



oui, UDS Group Inc có nợ là 8

Institute of Biomedical Research Corp có bao nhiêu cổ phiếu đang lưu hành?



UDS Group Inc có tổng cộng 193.39 cổ phiếu đang lưu hành

Institute of Biomedical Research Corp (MRES) Financier

Graphique du cours de l'action MRES